Below are the most recent publications written about "Ethinyl Estradiol" by people in Profiles.
-
Tobin NH, Brooker SL, Li F, Coombs RW, Cohn SE, Moran L, Leon M, Chotirosniramit N, Jalil EM, Chakalisa UA, Scarsi KK, Zorrilla CD, Godfrey C, Aldrovandi GM. Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. J Infect Dis. 2025 Mar 17; 231(3):583-594.
-
Haas DW, Cramer YS, Godfrey C, Rosenkranz SL, Aweeka F, Berzins B, Coombs R, Coughlin K, Moran LE, Gingrich D, Zorrilla CD, Baker P, Cohn SE, Scarsi KK. Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenet Genomics. 2020 04; 30(3):45-53.
-
Lin PH, Kuo TH, Chen CC, Jian CY, Chen CW, Wang KL, Kuo YC, Shen HY, Hsia SM, Wang PS, Lieu FK, Wang SW. Downregulation of testosterone production through luteinizing hormone receptor regulation in male rats exposed to 17a-ethynylestradiol. Sci Rep. 2020 01 31; 10(1):1576.
-
Wang G, Ma P, Zhang Q, Lewis J, Lacey M, Furukawa Y, O'Reilly SE, Meaux S, McLachlan J, Zhang S. Endocrine disrupting chemicals in New Orleans surface waters and Mississippi Sound sediments. J Environ Monit. 2012 May; 14(5):1353-64.
-
Kaneshiro B, Edelman A, Carlson NE, Nichols M, Forbes MM, Jensen J. A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use. Contraception. 2012 Apr; 85(4):351-8.
-
Mathews E, Braden TD, Williams CS, Williams JW, Bolden-Tiller O, Goyal HO. Mal-development of the penis and loss of fertility in male rats treated neonatally with female contraceptive 17alpha-ethinyl estradiol: a dose-response study and a comparative study with a known estrogenic teratogen diethylstilbestrol. Toxicol Sci. 2009 Dec; 112(2):331-43.
-
Fontenot HB, Harris AL. The latest advances in hormonal contraception. J Obstet Gynecol Neonatal Nurs. 2008 May-Jun; 37(3):369-74.
-
Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res. 2004; 6(1):R31-7.
-
Rice VM. Optimizing the dose of hormone replacement therapy. Int J Fertil Womens Med. 2002 Sep-Oct; 47(5):205-10.
-
Montgomery Rice V. Hormone replacement therapy: optimising the dose and route of administration. Drugs Aging. 2002; 19(11):807-18.